This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Formula E Championship Racing (A)
Higgins, Robert F.; Weber, JamesCase HBS-819011-EEntrepreneurshipFormula E founder and CEO Alejandro Aga obtained the rights to develop a new electric car racing series from the F d ration Internationale de l'Automobile (FIA). Agag needed to develop the series from scratch-developing a race car, finding teams willing to race, cities willing to host races, and sponsors, media partners, and investors willing to fund the series. The first race was one year away. How should Agag go about developing this new seri...Starting at €8.20
-
Formula E Championship Racing (B)
Higgins, Robert F.; Ma, Susie L.; Weber, JamesCase HBS-819012-EEntrepreneurshipFormula E's season three is nearly complete. CEO Alejandro Agag needs to examine his business model to ensure the racing series is positioned to grow sustainable in the years to come.Starting at €5.74
-
Formula E Championship Racing (A) and (B), Teaching Note
Higgins, Robert F.; Weber, JamesTeaching Note HBS-819101-EEntrepreneurshipTeaching note for cases 819011 and 819012.Starting at €0.00
-
La industria farmacéutica: los desafíos del nuevo siglo
Bradley, Stephen P.; Weber, JamesCase HBS-704S16StrategyProporciona una visión general de las numerosas fuerzas internas y externas que fueron impulsando el cambio en la industria farmacéutica mundial en el año 2003. Estas fuerzas - incluyendo presiones a la baja de los precios, las presiones políticas y sociales, el aumento de los costes de desarrollo, nuevas tecnologías, competidores nuevos y diferentes, la consolidación y las amenazas a sus modelos de negocio básicos - estaban cambiando la forma en...Starting at €8.20
-
Pfizer's Centers for Therapeutic Innovation (CTI)
Pisano, Gary P.; Weber, James; Szydlowski, KaitlynCase HBS-615024-EService and Operations ManagementIn 2010, Pfizer established four small research units in New York, Boston, San Francisco, and San Diego located close to several premier Academic Medical Centers (AMCs), or hospitals with adjoining medical schools. The goal of these units was to redesign collaboration with Pfizer and academic medical researchers with the purpose of developing new, innovative drugs candidates for testing in patients. Project teams consisted of Pfizer scientists an...Starting at €8.20
-
Longbow Capital Partners
Baker, Malcolm P.; Hanson, Samuel G.; Weber, JamesCase HBS-215026-EFinanceLongbow Capital Partners is a value-oriented long/short hedge fund focused on stocks in the energy sector. In January 2011, Longbow invested in NiSource, a Fortune 500 company that owns a diverse portfolio of regulated energy businesses. In late 2014, Longbow was deciding whether or not to maintain its position in NiSource. To make this decision, students must perform a discounted dividend analysis to determine the fundamental value of NiSource's...Starting at €8.20
-
Dogs of the Dow
Baker, Malcolm P.; Hanson, Samuel G.; Weber, JamesCase HBS-215020-EFinanceThis case describes the Dogs of the Dow investment strategy, value investing, and using dividend yields as a means to determine intrinsic value. It also describes exchange traded notes and a particular exchange traded note, known as the Dogs of the Dow, which tracks the performance of the 10 highest yielding stocks of the 30 stocks that make up the Dow Jones Industrial Average (DJIA). The case provides share price data, dividend data, and financi...Starting at €8.20
-
The Hain Celestial Group
Bell, David E.; Alvarez, Jose B.; Weber, James; Shelman, MaryCase HBS-516007-EStrategyHain Celestial manufactured natural and organic food and personal care products to be sold to retailers of these products. The company had grown successfully and profitably through acquisitions and organically for two decades. In late 2015, Hain faced challenges on several fronts. First, new consumers were interested in these products and these consumers had characteristics different from those of historical consumers in the segment. Second, the ...Starting at €8.20
-
Merrill Lynch: Opción Integrada (abreviado)
McFarlan, F. Warren; Weber, JamesCase HBS-304S26MarketingMerrill Lynch, una firma de corretaje de servicio completo con $ 1,5 billones en activos de clientes, está siendo atacada por tanto de descuento y las firmas de corretaje electrónico. Responde con Integrado Choice, una suite de productos diseñados para clientes de captura, desde el do-it-yourself inversor que no quieren usar un intermediario para los clientes que quieren confiar plenamente en un corredor. La estrategia es de alto riesgo y requier...Starting at €8.20
-
OrganJet and GuardianWings
Battilana, Julie; Weber, JamesCase HBS-413068-ELeadership and People ManagementStarting at €8.20